Marjorie R Levinstein

11PUBLICATIONS
31CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMedical virologyMolecular medicineToxicology (incl. clinical toxicology)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 27, 2025
Cocaine chemogenetics blunts drug-seeking by synthetic physiology.

Juan L Gomez, Christopher J Magnus, Jordi Bonaventura

|Dec 05, 2024
Reply to "Letter to the Editor regarding 'Unique pharmacodynamic properties and low abuse liability of the μ-opioid receptor ligand (S)-methadone'".

Marjorie R Levinstein, Paulo A De Oliveira, Nil Casajuana-Martin

|Jan 30, 2024
Sex dependence of opioid-mediated responses to subanesthetic ketamine in rats.

Tommaso Di Ianni, Sedona N Ewbank, Marjorie R Levinstein

|Dec 25, 2023
Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone.

Marjorie R Levinstein, Paulo A De Oliveira, Nil Casajuana-Martin

|Jul 12, 2023
Exploring the role of mu opioid receptors in the therapeutic potential and abuse liability of (S)-ketamine.

Marjorie R Levinstein, Michael Michaelides

|Mar 30, 2023
Unique pharmacodynamic properties and low abuse liability of the μ-opioid receptor ligand (S)-methadone.

Michael Michaelides, Marjorie Levinstein, Paulo De Oliveira

Pageof 2